UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature genetics, ISSN 1061-4036, 11/2009, Volume 41, Issue 11, pp. 1243 - 1246
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Medical genetics | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Genetics of eukaryotes. Biological and molecular evolution | Medical sciences | Chromosome aberrations | Chromosome Deletion | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Amino Acid Sequence | Cell Line | Humans | Janus Kinase 2 - genetics | Recombinant Fusion Proteins - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Receptors, Cytokine - chemistry | Base Sequence | Gene Rearrangement | Janus Kinase 2 - metabolism | Receptors, Purinergic P2 - genetics | Receptors, Purinergic P2 - metabolism | Down Syndrome - genetics | Down Syndrome - complications | Recombinant Fusion Proteins - genetics | Mice | Receptors, Cytokine - metabolism | Receptors, Cytokine - genetics | Gene mutations | Genetic aspects | Acute lymphocytic leukemia | Research | Down syndrome | Health aspects | Risk factors | Studies | Medical research | Hospitals | Genomics | Cell cycle | Genetics | Kinases | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 16, pp. 1541 - 1552
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Translocation, Genetic | Prognosis | Humans | Risk Factors | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Hematopoietic Stem Cell Transplantation | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Survival Rate | Combined Modality Therapy | Immunotherapy - adverse effects | Incidence | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Female | Child | Care and treatment | Relapse | Patient outcomes | Acute lymphocytic leukemia | Children | Health aspects | Risk factors | Diseases | Chemotherapy | Acute lymphatic leukemia | Medical prognosis | Leukemia | Lymphatic leukemia | Gene expression | Kinases | Cancer therapies | Chromosomes | Children & youth | Cancer | Low income groups | Pediatrics | High income | Transcription factors | Young adults | Genomics | Proteins | Epigenetics | Mutation | Age | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 2016, Volume 91, Issue 11, pp. 1645 - 1666
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - epidemiology | Immunotherapy, Adoptive | Humans | Salvage Therapy | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | T-Lymphocytes - transplantation | Neoplasm, Residual | Stem Cell Transplantation | Antibodies, Bispecific - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Bone Marrow - pathology | Central Nervous System Neoplasms - prevention & control | Adult | Receptors, Antigen, T-Cell - immunology | T-Lymphocytes - immunology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - etiology | Pediatrics | Care and treatment | Chemotherapy | Usage | Adults | Acute lymphocytic leukemia | Health aspects | Risk factors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Archives of pathology & laboratory medicine (1976), ISSN 0003-9985, 02/2020, Volume 144, Issue 2, pp. 150 - 155
Pathology | Life Sciences & Biomedicine | Medical Laboratory Technology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Fusion Proteins, bcr-abl - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Mutation | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Lymphomas | Platelet-derived growth factor | B cells | Gene expression | Genes | BCR protein | Transcription factors | Ikaros protein | RNA-directed DNA polymerase | Erythropoietin | Leukemia | Oncology | Kinases | Pax5 protein | Down's syndrome | Janus kinase 2 | Zinc finger proteins | Children | Fusion protein | Age | Translocation | Immunoglobulins | Young adults | Acute lymphatic leukemia | Cytokines | Preservation | Lymphatic leukemia | Lymphoma | Hemopoiesis | Polymerase chain reaction | Algorithms | Lymphocytes B | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 03/2010, Volume 116, Issue 5, pp. 1165 - 1176
Cytogenetic and molecular abnormalities | Acute lymphoblastic leukemia | Targeted therapy | Philadelphia chromosome | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Recurrence | Precursor Cell Lymphoblastic Leukemia-Lymphoma - epidemiology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Prognosis | Humans | Chromosome Aberrations | Hematopoietic Stem Cell Transplantation | Adult | Philadelphia Chromosome | Care and treatment | Diagnosis | Lymphocytic leukemia | Patient outcomes | Risk factors | Cancer | Index Medicus | Abridged Index Medicus | cytogenetic and molecular abnormalities | targeted therapy | acute lymphoblastic leukemia
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2006, Volume 354, Issue 2, pp. 166 - 178
Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Prognosis | Risk Assessment | Humans | Central Nervous System Neoplasms - therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Combined Modality Therapy | Gene Expression Profiling | Methotrexate - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Stem Cell Transplantation | Dexamethasone - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Anti-Inflammatory Agents - therapeutic use | Adult | Remission Induction - methods | Asparaginase - therapeutic use | Child | Precursor Cell Lymphoblastic Leukemia-Lymphoma - radiotherapy | Care and treatment | Acute lymphocytic leukemia | Diagnosis | Pediatrics | Heart attacks | Risk assessment | Teenagers | Drug therapy | Drug resistance | Age | Index Medicus | Abridged Index Medicus
Journal Article